1298031-94-3 Usage
General Description
8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine is a chemical compound with a molecular formula C7H5BrClN4. It is a heterocyclic compound with an imidazo[1,2-b]pyridazine backbone and substitution of bromine, chlorine, and methyl groups. 8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine has potential applications in medicinal chemistry and drug development due to its ability to interact with biological targets. It may have biological activity as an agonist or antagonist of specific receptors, making it a valuable tool for research in pharmacology. Additionally, 8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine may serve as a precursor for the synthesis of other functionalized compounds with diverse properties and applications. Further research on this compound is necessary to fully understand its potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1298031-94-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,8,0,3 and 1 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1298031-94:
(9*1)+(8*2)+(7*9)+(6*8)+(5*0)+(4*3)+(3*1)+(2*9)+(1*4)=173
173 % 10 = 3
So 1298031-94-3 is a valid CAS Registry Number.
1298031-94-3Relevant articles and documents
COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
-
Page/Page column 184; 185, (2019/01/06)
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
-
Page/Page column 68, (2011/05/11)
The present invention relates to novel imidazo[1,2-b]pyridazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.
